Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sedation Strategies in Mechanically Ventilated Critically Ill Patients
NCT00221520Phase 3Unknown
- Start
- Feb 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of midazolam in respiratory failure (2 arms). Primary endpoints: Post-traumatic stress disorders, Anxiety and 1 more. Status: unknown.
02
Drugs
midazolam
03
Conditions
respiratory failure
Beyond the preview
Go deeper on NCT00221520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00221520.